Tholander B., Koliadi A., Botling J., Dahlstrand H., Von Heideman A., Ahlström H., Öberg K., & Ullenhag G. J. (2020). Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. Upsala Journal of Medical Sciences, 125(4), 325–329. https://doi.org/10.1080/03009734.2020.1826612